Singapore - English - HSA (Health Sciences Authority)

smartfuture pte ltd - clinical chemistry - medcheck smbg system is self-test medical device and intended for both home testing and for professional use to monitor the blood glucose (β-d-glucose) levels from fresh capillary whole blood obtained from the finger tip. it is indicated to be used by diabetics at home or in a clinical setting by professional healthcare personnel to measure the glucose concentration for aiding diabetes management. the owner can only use sfbg01 blood glucose meter with sfts01/sftts02 blood glucose test strips.

Singapore - English - HSA (Health Sciences Authority)

smartfuture pte ltd - cardiovascular - this device uses the oscillometric method to automatically measure systolic and diastolic blood pressure as well as heart rate. the measurement position is at human being’s arm. all values can be read out in lcd panel. the device is designed for home use and recommended for use by adults aged 18 years and older with upper arm circumference ranging from 23 to 33 cm.

Singapore - English - HSA (Health Sciences Authority)

smartfuture pte ltd - cardiovascular - the device is intended to be used for measuring, displaying, reviewing and storing of multiple physiological parameters including ecg, pulse oxygen saturation (spo2), pulse rate, temperature and blood pressure variation in home or healthcare facilities environment. ecg and blood pressure variation is intended for use with adult. the data and results provided by this device are for pre-check screening purpose only and cannot be directly used for diagnostic or treatment.

Malta - English - Medicines Authority

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - rosuvastatin - film-coated tablet - rosuvastatin 5 mg - lipid modifying agents

Malta - English - Medicines Authority

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - rosuvastatin - film-coated tablet - rosuvastatin 10 mg - lipid modifying agents

Malta - English - Medicines Authority

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - rosuvastatin - film-coated tablet - rosuvastatin 20 mg - lipid modifying agents

Malta - English - Medicines Authority

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - rosuvastatin - film-coated tablet - rosuvastatin 40 mg - lipid modifying agents

Australia - English - Department of Health (Therapeutic Goods Administration)

ms health pty ltd - mifepristone, quantity: 200 mg - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; povidone - mifepristone linepharma 200 mg tablet is indicated in females of childbearing age for preparation for the action of registered prostaglandin analogues that are indicated for the termination of pregnancy for medical reasons beyond the first trimester.

United States - English - NLM (National Library of Medicine)

bayer healthcare pharmaceuticals inc. - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 250 mg - cipro is indicated in adult patients for treatment of skin and skin structure infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, proteus vulgaris, providencia stuartii, morganella morganii, citrobacter freundii, pseudomonas aeruginosa, methicillin-susceptible staphylococcus aureus, methicillin-susceptible staphylococcus epidermidis, or streptococcus pyogenes. cipro is indicated in adult patients for treatment of bone and joint infections caused by enterobacter cloacae, serratia marcescens, or pseudomonas aeruginosa. cipro is indicated in adult patients for treatment of complicated intra-abdominal infections (used in combination with metronidazole) caused by escherichia coli, pseudomonas aeruginosa, proteus mirabilis, klebsiella pneumoniae, or bacteroides fragilis. cipro is indicated in adult patients for treatment of infectious diarrhea caused by escherichia coli (enterotoxigenic isolates), campylobacter jejuni, shigella boydii † , shigella dysenteri

Ireland - English - HPRA (Health Products Regulatory Authority)

biotest pharma gmbh - human plasma protein - solution for infusion - 100 gram(s)/litre - immunoglobulins, normal human; immunoglobulins, normal human, for intravascular adm.